Wake Forest

Wake Forest researchers are in the midst of an ongoing precision oncology trial to see how NGS-based tumor profiling and liquid biopsy assays can be implemented.

NEW YORK (GenomeWeb News) – Wake Forest University and spin-out company NanoMedica have received $860,000 in funding to move a bead-based genetic sequencing drug discovery technology closer to commercialization, Wake Forest said today.

Beyond the SNP

Premium

Genome-wide association studies have put forward a vast number of SNPs associated with disease. Once you have those SNPs, the search is on for the causal variant.

News Scan

Premium

Thermo Fisher Scientific, North Carolina Biotechnology Center, Life Technologies, Cenix BioScience, AstraZeneca, MultiCell Technologies, Maxim Biotech, CyBio, Axxam, PerkinElmer, Sangmyung University

Tech Transfer Tidbits

Premium

JumpStart and Case Tech Ventures Invest in Neuros Medical; OGI Bets on UWO Spinout Cytognomix; Forma Collaborates with Singapore's ETC; and more …

For now, the center is planning how to create a venue that would grow the state's established biotech sector by capitalizing on the nanotech sector that has emerged in recent years in its Piedmont Triad region.

People in the News

Premium

Bruno Sobral, Michael Gilman, Kathy Gibson, Uwe Christians,Herbert Fritsche, Dan Crowther

Direct-to-consumer genetic testing companies have based their products on what scientists have accomplished, but the caveat is that the science is still in its early days.

A majority of US tech-transfer offices said their main goals are to provide a service to faculty entrepreneurs and translate university research into commercial products — but much less so to maximize licensing revenue or provide research support, according to the survey.

Pages

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.

NPR reports that government and private insurers are being slow to cover recently approved CAR-T cell therapies.

CNBC reports that there are thousands of genetic tests available for consumers to chose between.

In Nature this week: genomic analysis of ducks, whole-genome doubling among tumor samples, and more.